Stromal fibroblasts and other cells in tumor tissue shape the immunosuppressive environment of the tumor through TGFβ signaling, inhibiting the anti-tumor activity of immune cells and preventing or diminishing the effects of anti-cancer immunotherapy (Chakravarthy et al., 2018). The gene discussed is TGFB1; the disease is cancer.